The PIEZO1 Gene Dehydrated Hereditary Stomatocytosis Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, aimed at detecting mutations in the PIEZO1 gene, which are associated with Dehydrated Hereditary Stomatocytosis (DHS). DHS is a rare genetic condition characterized by the alteration of red blood cell shapes, leading to an array of symptoms including anemia, jaundice, and splenomegaly. The test plays a crucial role in the accurate diagnosis of DHS, facilitating early intervention and management of the condition. Priced at 4400 AED, this genetic test involves analyzing the patient's DNA to identify specific mutations in the PIEZO1 gene, providing valuable insights for personalized treatment plans. DNA Labs UAE ensures the provision of this test with high precision and reliability, leveraging advanced genomic technologies for accurate results.
The HBB Gene Delta-Beta Thalassemia Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the HBB gene, which are responsible for delta-beta thalassemia. Delta-beta thalassemia is a rare blood disorder that reduces the production of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. This condition can lead to anemia, fatigue, and more severe health complications if not properly diagnosed and managed.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test provides crucial information for the accurate diagnosis and treatment planning for individuals suspected of having delta-beta thalassemia. The test involves analyzing the patient's DNA to detect specific mutations in the HBB gene that are known to cause the condition. The process is sophisticated and requires advanced technological tools and expertise in genetic analysis.
The cost of the HBB Gene Delta-Beta Thalassemia Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the collection of the sample, the intricate analysis performed by highly skilled geneticists, and the detailed reporting of the results. For patients and families affected by delta-beta thalassemia, this test is a critical step towards understanding their condition and exploring potential treatment options. It offers a pathway to better health management and a higher quality of life for those impacted by this genetic disorder.
The RPS28 Gene Diamond Blackfan Anemia Type 15 with Mandibulofacial Dysostosis Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the RPS28 gene. These mutations are associated with a rare and complex form of Diamond Blackfan Anemia (DBA) Type 15, characterized not only by the bone marrow's failure to produce sufficient red blood cells but also by mandibulofacial dysostosis, a condition affecting the development of the face and jaw.
Diamond Blackfan Anemia is a congenital erythroid aplasia that typically presents early in infancy. Patients with DBA show symptoms such as fatigue, pallor, and growth retardation, due to anemia. The specific subtype, associated with mutations in the RPS28 gene, includes additional physical malformations, particularly affecting craniofacial development. This genetic test is crucial for accurate diagnosis, guiding treatment plans, and providing information on the prognosis.
The cost of the RPS28 Gene Diamond Blackfan Anemia Type 15 with Mandibulofacial Dysostosis Genetic Test at DNA Labs UAE is 4400 AED. Conducted in a state-of-the-art facility, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic alterations in the RPS28 gene. Results from this test can help in confirming the diagnosis, enabling personalized treatment strategies, and offering genetic counseling for affected families.
The RPS19 Gene Diamond-Blackfan Anemia Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. Priced at 4400 AED, this test is designed to identify mutations in the RPS19 gene, which are known to cause Diamond-Blackfan Anemia Type 1 (DBA). DBA is a rare inherited bone marrow failure syndrome characterized by an inability to produce sufficient red blood cells, leading to severe anemia and various other complications. The test involves collecting a DNA sample from the patient, usually through a blood draw, and analyzing it for specific genetic alterations associated with the condition. By identifying mutations in the RPS19 gene, this test can provide a definitive diagnosis of Diamond-Blackfan Anemia Type 1, enabling targeted treatment and management strategies to improve patient outcomes.
The "RPS26 Gene Diamond-Blackfan Anemia Type 10 Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, aimed at detecting mutations in the RPS26 gene, which are linked to Diamond-Blackfan Anemia (DBA) Type 10. DBA is a rare, inherited bone marrow failure disorder characterized by an inability to produce sufficient red blood cells, leading to severe anemia and various other complications. The test is crucial for individuals suspected of having this specific subtype of DBA, as it allows for a precise genetic diagnosis, enabling tailored treatment plans and genetic counseling for affected families. The cost of this comprehensive genetic test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify mutations in the RPS26 gene. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a critical step towards personalized medicine for patients with Diamond-Blackfan Anemia.
The "RPL26 Gene Diamond-Blackfan Anemia Type 11 Genetic Test" is a specific diagnostic tool used to identify mutations in the RPL26 gene, which are linked to Diamond-Blackfan Anemia (DBA) Type 11. DBA is a rare, inherited bone marrow failure disorder characterized by an inability to produce red blood cells, leading to severe anemia and various congenital abnormalities. The test plays a crucial role in confirming the diagnosis of DBA Type 11, enabling targeted treatment strategies and genetic counseling for affected families.
Performed at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to search for mutations in the RPL26 gene that are known to cause the condition. The test cost is set at 4400 AED, reflecting the specialized nature of the testing process and the expertise required to accurately interpret the results. By providing a definitive diagnosis, the test allows healthcare providers to tailor treatment plans to the specific needs of the patient, potentially improving outcomes and quality of life for those affected by this rare genetic disorder.
The RPL15 Gene Diamond-Blackfan Anemia Type 12 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the RPL15 gene, which are linked to Diamond-Blackfan Anemia (DBA) Type 12. Diamond-Blackfan Anemia is a rare genetic disorder characterized by a failure of the bone marrow to produce sufficient red blood cells, leading to anemia and various other health complications. The test is particularly important for individuals with a family history of DBA or those exhibiting symptoms related to anemia, as early detection can significantly influence management and treatment options.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test employs advanced genetic sequencing techniques to accurately analyze the RPL15 gene for any abnormalities that could be responsible for the condition. Given the complexity of the test and the sophisticated technology involved, the cost is set at 4400 AED. This investment not only provides critical insights into the patient's genetic makeup regarding DBA but also aids in the broader understanding of the disease, potentially benefiting family members and contributing to future research in genetic disorders.
By choosing DNA Labs UAE for the RPL15 Gene Diamond-Blackfan Anemia Type 12 Genetic Test, patients can expect a high level of accuracy, confidentiality, and professional support throughout the testing process, ensuring they receive the most reliable information for their health and wellbeing.
The RPS29 Gene Diamond-Blackfan Anemia Type 13 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the RPS29 gene associated with Diamond-Blackfan Anemia (DBA) Type 13. Diamond-Blackfan Anemia is a rare genetic disorder characterized by a failure of the bone marrow to produce adequate red blood cells, leading to severe anemia and various other complications. The condition is often diagnosed in early childhood and can be inherited in an autosomal dominant manner, though sporadic cases also occur.
The test specifically targets the RPS29 gene, mutations in which have been identified as one of the genetic causes of DBA. By analyzing the genetic material extracted from a blood sample, the test can confirm or rule out the presence of these mutations, thus aiding in the accurate diagnosis of the disorder. This is crucial for the management and treatment planning for affected individuals, as early intervention can significantly improve outcomes.
The cost of the RPS29 Gene Diamond-Blackfan Anemia Type 13 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated technology and expert analysis required to accurately identify mutations within the RPS29 gene. Given the specialized nature of this test, it is a valuable resource for families with a history of DBA or for individuals exhibiting symptoms consistent with the disorder, offering them a clear path towards understanding their condition and exploring treatment options.
The TSR2 Gene Diamond-Blackfan Anemia Type 14 with Mandibulofacial Dysostosis genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TSR2 gene. These mutations are known to cause Diamond-Blackfan Anemia Type 14, a rare genetic disorder characterized by bone marrow failure that leads to insufficient red blood cell production. The condition often presents in infancy or early childhood and can be associated with physical anomalies, including mandibulofacial dysostosis, a condition that affects the development of the face and jaw.
This comprehensive genetic test is crucial for accurate diagnosis, allowing for tailored treatment plans and management strategies to improve the quality of life for affected individuals. The test cost is set at 4400 AED, reflecting the sophisticated technology and expertise required to perform the analysis. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing services, this test represents a vital resource for families seeking answers to complex genetic conditions.
The RPS24 Gene Diamond-Blackfan Anemia Type 3 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE. This test is designed to detect mutations in the RPS24 gene, which are associated with Diamond-Blackfan Anemia (DBA) Type 3, a rare and inherited form of anemia. DBA is characterized by the failure of the bone marrow to produce sufficient red blood cells, leading to fatigue, weakness, and potential developmental issues. The RPS24 gene plays a crucial role in the production of ribosomes, which are essential for protein synthesis within cells, including those involved in hematopoiesis or blood formation.
The genetic test is crucial for individuals with a family history of DBA or those exhibiting symptoms of the disorder, as it provides a definitive diagnosis by identifying specific genetic mutations. Early diagnosis through this genetic testing can lead to more effective management and treatment strategies for affected individuals.
Priced at 4400 AED, the test is conducted at the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of the results. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for the presence of mutations in the RPS24 gene. The outcome of this test not only aids in the diagnosis of DBA Type 3 but also helps in genetic counseling for families, guiding decisions regarding future pregnancies, and understanding the risk of DBA in siblings or future offspring.
